title: Onychomadesis and onycholysis associated with capecitabine.
authors.forename: G Y
authors.initials: GY
authors.lastname: Chen
authors.forename: Y H
authors.initials: YH
authors.lastname: Chen
authors.forename: M M
authors.initials: MM
authors.lastname: Hsu
authors.forename: C J
authors.initials: CJ
authors.lastname: Tsao
authors.forename: W C
authors.initials: WC
authors.lastname: Chen
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D005500:Follow-Up Studies; D006801:Humans; D009264:Nails, Malformed / Q000139:chemically induced*; D011355:Prodrugs / Q000009:adverse effects*
chemical_list: D000964:Antimetabolites, Antineoplastic; D011355:Prodrugs; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil